Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine L Cook

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Cancer Research|January 11, 2015
Interferon regulatory factor-1 signaling regulates the switch between autophagy and apoptosis to determine breast cancer cell fateJessica L Schwartz-Roberts, Katherine L Cook, Chun Chen, et al.
Cell Reports. Medicine|January 1, 2025
Endocrine-targeting therapies shift the breast microbiome to reduce estrogen receptor-α breast cancer riskAlana A Arnone, Yu-Ting Tsai, J Mark Cline, et al.
Cancers|December 23, 2023
A Novel Metastatic Estrogen Receptor-Expressing Breast Cancer Model with Antiestrogen ResponsivenessKendall L Langsten, Lihong Shi, Adam S Wilson, et al.
JCI Insight|March 6, 2025
Metabolic and transcriptional effects of bazedoxifene/conjugated estrogens in a model of obesity-associated breast cancer riskErin D Giles, Katherine L Cook, Ramsey M Jenschke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2022
Circulating Immune Bioenergetic, Metabolic, and Genetic Signatures Predict Melanoma Patients' Response to Anti-PD-1 Immune Checkpoint BlockadePierre L Triozzi, Elizabeth R Stirling, Qianqian Song, et al.
Molecular Cancer Research : MCR|October 20, 2019
Neoadjuvant Chemotherapy Shifts Breast Tumor Microbiota Populations to Regulate Drug Responsiveness and the Development of MetastasisAkiko Chiba, Alaa Bawaneh, Christine Velazquez, et al.
Physiological Reports|April 19, 2022
Diet impacts triple-negative breast cancer growth, metastatic potential, chemotherapy responsiveness, and doxorubicin-mediated cardiac dysfunctionManuel U Ramirez, Kenysha Y J Clear, Zipporah Cornelius, et al.
Journal of the National Cancer Institute|September 10, 2016
Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical ModelLeena Hilakivi-Clarke, Anni Wärri, Kerrie B Bouker, et al.
Frontiers in Microbiomes|December 15, 2025
A Standardized Method for Vertical Sleeve Gastrectomy Bariatric Surgery Investigations in CancerArvind V Ramesh, Sydney C Joseph, Margaret S Bohm, et al.
Oncogene|January 24, 2019
Elevated leptin disrupts epithelial polarity and promotes premalignant alterations in the mammary glandIliana Tenvooren, Mónica Z Jenks, Hamza Rashid, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Cancer Research|January 11, 2015
Interferon regulatory factor-1 signaling regulates the switch between autophagy and apoptosis to determine breast cancer cell fateJessica L Schwartz-Roberts, Katherine L Cook, Chun Chen, et al.
Cell Reports. Medicine|January 1, 2025
Endocrine-targeting therapies shift the breast microbiome to reduce estrogen receptor-α breast cancer riskAlana A Arnone, Yu-Ting Tsai, J Mark Cline, et al.
Cancers|December 23, 2023
A Novel Metastatic Estrogen Receptor-Expressing Breast Cancer Model with Antiestrogen ResponsivenessKendall L Langsten, Lihong Shi, Adam S Wilson, et al.
JCI Insight|March 6, 2025
Metabolic and transcriptional effects of bazedoxifene/conjugated estrogens in a model of obesity-associated breast cancer riskErin D Giles, Katherine L Cook, Ramsey M Jenschke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2022
Circulating Immune Bioenergetic, Metabolic, and Genetic Signatures Predict Melanoma Patients' Response to Anti-PD-1 Immune Checkpoint BlockadePierre L Triozzi, Elizabeth R Stirling, Qianqian Song, et al.
Molecular Cancer Research : MCR|October 20, 2019
Neoadjuvant Chemotherapy Shifts Breast Tumor Microbiota Populations to Regulate Drug Responsiveness and the Development of MetastasisAkiko Chiba, Alaa Bawaneh, Christine Velazquez, et al.
Physiological Reports|April 19, 2022
Diet impacts triple-negative breast cancer growth, metastatic potential, chemotherapy responsiveness, and doxorubicin-mediated cardiac dysfunctionManuel U Ramirez, Kenysha Y J Clear, Zipporah Cornelius, et al.
Journal of the National Cancer Institute|September 10, 2016
Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical ModelLeena Hilakivi-Clarke, Anni Wärri, Kerrie B Bouker, et al.
Frontiers in Microbiomes|December 15, 2025
A Standardized Method for Vertical Sleeve Gastrectomy Bariatric Surgery Investigations in CancerArvind V Ramesh, Sydney C Joseph, Margaret S Bohm, et al.
Oncogene|January 24, 2019
Elevated leptin disrupts epithelial polarity and promotes premalignant alterations in the mammary glandIliana Tenvooren, Mónica Z Jenks, Hamza Rashid, et al.
Pageof 8